These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12870681)

  • 1. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes?
    Harries AD; Chimzizi RB; Nyirenda TE; van Gorkom J; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):616-22. PubMed ID: 12870681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
    Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB control programmes: the challenges for Africa.
    Harries T
    Afr Health; 1996 Nov; 19(1):19-20. PubMed ID: 12291916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
    Harries AD; Hargreaves NJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
    Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
    Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
    Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing HIV care for tuberculosis patients in sub-Saharan Africa.
    Harries AD; Boxshall M; Phiri S; van Gorkom J; Zachariah R; Squire SB; Makombe SD; Kwanjana J; Gondwett M
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1306-11. PubMed ID: 17167945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.
    Libamba E; Makombe S; Harries AD; Chimzizi R; Salaniponi FM; Schouten EJ; Mpazanje R
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1062-71. PubMed ID: 16229216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care in-depth. Tuberculosis and HIV.
    Maher D
    Afr Health; 1996 Nov; 19(1):17-8. PubMed ID: 12291915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.
    Bonnet MM; Pinoges LL; Varaine FF; Oberhauser BB; O'Brien DD; Kebede YY; Hewison CC; Zachariah RR; Ferradini LL
    AIDS; 2006 Jun; 20(9):1275-9. PubMed ID: 16816556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.
    Zampoli M; Kilborn T; Eley B
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):417-23. PubMed ID: 17394688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
    Godfrey-Faussett P; Maher D; Mukadi YD; Nunn P; Perriëns J; Raviglione M
    Bull World Health Organ; 2002; 80(12):939-45. PubMed ID: 12571721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.
    Howard AA; El-Sadr WM
    Clin Infect Dis; 2010 May; 50 Suppl 3():S238-44. PubMed ID: 20397954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.